Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Antengene Biologics Limited

Clinical trials sponsored by Antengene Biologics Limited, explained in plain language.

Now part of Antengene Corporation Limited 6996 HKEX

Biopharmaceutical company developing innovative oncology and hematology drugs.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet recruiting 1 Terminated 1

Can a single drug calm three different autoimmune diseases? a new trial puts ATG-201 to the test.

Disease control Not yet recruiting

This phase 1 trial is testing an experimental drug called ATG-201 in adults with systemic lupus erythematosus, systemic sclerosis, or Sjögren's disease. ATG-201 is designed to bind to specific proteins on immune cells, potentially quieting the overactive immune response that driv…

Phase: PHASE1 • Sponsor: Antengene Biologics Limited • Aim: Disease control

Last updated Jul 30, 2026 00:00 UTC